{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:10Z","timestamp":1793388430984,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Counsel of Technological and Scientific Development","award":["134411\/2015-3"],"award-info":[{"award-number":["134411\/2015-3"]}]},{"name":"National Counsel of Technological and Scientific Development","award":["310953\/2015-4"],"award-info":[{"award-number":["310953\/2015-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13643-017-0491-x","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T12:01:00Z","timestamp":1494849660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Paraquat and Parkinson\u2019s disease: a systematic review protocol according to the OHAT approach for hazard identification"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-734X","authenticated-orcid":false,"given":"Carolina","family":"Vaccari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"El Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Lauro V.","family":"de Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"491_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/bss0660085","volume":"66","author":"JT Greenamyre","year":"1999","unstructured":"Greenamyre JT, MacKenzie G, Peng T, Stephans SE. Mitochondrial dysfunction in Parkinson\u2019s disease. Biochem Soc Symp. 1999;66:85\u201397.","journal-title":"Biochem Soc Symp"},{"issue":"suppl 3","key":"491_CR2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner P. Oxidative stress in Parkinson\u2019s disease. Ann Neurol. 2003;53 suppl 3:S26\u201336.","journal-title":"Ann Neurol"},{"key":"491_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/152308603322110896","volume":"5","author":"M Ebadi","year":"2003","unstructured":"Ebadi M, Sharma SK. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson\u2019s disease. Antioxid Redox Signal. 2003;5:319\u201335.","journal-title":"Antioxid Redox Signal"},{"issue":"suppl 3","key":"491_CR4","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/ana.10512","volume":"53","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Olanow CW. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson\u2019s disease. Ann Neurol. 2003;53 suppl 3:S73\u201384.","journal-title":"Ann Neurol"},{"key":"491_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1566524033361690","volume":"3","author":"DC Alves","year":"2003","unstructured":"Alves DC. Recent advances on a-synuclein cell biology: functions and dysfunctions. Curr Mol Med. 2003;3:17\u201324.","journal-title":"Curr Mol Med"},{"key":"491_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-813X(02)00099-2","volume":"23","author":"DA Monte Di","year":"2002","unstructured":"Di Monte DA, Lavasani M, Manning-Bog AB. Environmental factors in Parkinson\u2019s disease. Neurotoxicology. 2002;23:487\u2013502.","journal-title":"Neurotoxicology"},{"key":"491_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.10487","volume":"53","author":"TT Warner","year":"2003","unstructured":"Warner TT, Schapira AH. Genetic and environmental factors in the cause of Parkinson\u2019s disease. Ann Neurol. 2003;53:16\u201325.","journal-title":"Ann Neurol"},{"key":"491_CR8","first-page":"979","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Sci Transl Med. 1983;219:979\u201380.","journal-title":"Sci Transl Med"},{"key":"491_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1293\/tox.2015-0020","volume":"28","author":"XJ He","year":"2015","unstructured":"He XJ, Uchida K, Megumi C, Tsuge N, Nakayama H. Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in C57BL mice. J Toxicol Pathol. 2015;28:197\u2013206.","journal-title":"J Toxicol Pathol"},{"key":"491_CR10","doi-asserted-by":"crossref","first-page":"e0169560","DOI":"10.1371\/journal.pone.0169560","volume":"12","author":"H Jing","year":"2017","unstructured":"Jing H, Wang S, Wang M, Fu W, Zhang C, Xu D. Isobavachalcone attenuates MPTP-induced Parkinson\u2019s disease in mice by inhibition of microglial activation through NF-\u03baB pathway. PLoS One. 2017;12:e0169560.","journal-title":"PLoS One"},{"key":"491_CR11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuropharm.2016.09.028","volume":"113","author":"D Elgueta","year":"2017","unstructured":"Elgueta D, Aymerich MS, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, et al. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson\u2019s disease. Neuropharmacology. 2017;113:110\u201323.","journal-title":"Neuropharmacology"},{"key":"491_CR12","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1074\/jbc.M708451200","volume":"283","author":"Q Fei","year":"2002","unstructured":"Fei Q, McCormack AL, Di Monte DA, Ethell DW. Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J Biol Chem. 2002;283:3357\u201364.","journal-title":"J Biol Chem"},{"key":"491_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","volume":"88","author":"JR Richardson","year":"2005","unstructured":"Richardson JR. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci. 2005;88:193\u2013201.","journal-title":"Toxicol Sci"},{"key":"491_CR14","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/hmg\/ddm249","volume":"16","author":"W Yang","year":"2007","unstructured":"Yang W, Chen L, Ding Y, Zhuang X, Kang UJ. Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Hum Mol Genet. 2007;16:2900\u201310.","journal-title":"Hum Mol Genet"},{"key":"491_CR15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/15287390802329364","volume":"71","author":"JM Mor\u00e1n","year":"2008","unstructured":"Mor\u00e1n JM, Gonzalez-Polo RA, Ortiz-Ortiz MA, Niso-Santano M, Soler G, Fuentes JM. Identification of genes associated with paraquat-induced toxicity in SH-SY5Y cells by PCR array focused on apoptotic pathways. J Toxicol Environ Health A. 2008;71:1457\u201367.","journal-title":"J Toxicol Environ Health A"},{"key":"491_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.toxlet.2009.08.024","volume":"191","author":"W Yang","year":"2009","unstructured":"Yang W, Tiffany-Castiglioni E, Koh HC, Sona IH. Paraquat activates the IRE1\/ASK1\/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol Lett. 2009;191:203\u201310.","journal-title":"Toxicol Lett"},{"key":"491_CR17","unstructured":"Paraquat Information Center on behalf of Syngenta Crop Protection AG. http:\/\/paraquat.com\/use\/crops . Accessed 03 Nov 2016."},{"key":"491_CR18","first-page":"75","volume":"10","author":"M Esfahani","year":"2012","unstructured":"Esfahani M. Effects of pre-harvest application of paraquat on grain moisture reduction, grain yield and quality of rapeseed (Brassica napus L.) cultivars. Caspian J Environ Sci. 2012;10:75\u201382.","journal-title":"Caspian J Environ Sci"},{"key":"491_CR19","unstructured":"ANVISA (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria). Parecer T\u00e9cnico\u00a0de Reavalia\u00e7\u00e3o [Technical report of reevaluation] n\u00b01 GGTOX\/ANVISA, 2015.\u00a0 http:\/\/portal.anvisa.gov.br\/documents\/33880\/2541353\/CP%2B94-2015%2B-%2BNT.pdf\/50fb348f-3c2a-4992-a3a2-ca89fd4d2127 . Accessed 11 Nov 2016."},{"key":"491_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2007.04.018","volume":"1155","author":"K Kuter","year":"2007","unstructured":"Kuter K, Smia\u0142owska M, Wieronska J, Zieba B, Wardas J, Pietraszek M, et al. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Res. 2007;1155:196\u2013207.","journal-title":"Brain Res"},{"key":"491_CR21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11064-010-0163-x","volume":"35","author":"K Kuter","year":"2010","unstructured":"Kuter K, Nowak P, Golembiowska K, Ossowska K. Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats: a comparison with peripheral tissues. Neurochem Res. 2010;35:1121\u201330.","journal-title":"Neurochem Res"},{"key":"491_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/taap.1996.0054","volume":"137","author":"HH Liou","year":"1996","unstructured":"Liou HH, Chen RC, Tsai YF, Chen WP, Chang YC, Tsai MC. Effects of paraquat on the substantia nigra of the Wistar rats: neurochemical, histological, and behavioral studies. Toxicol Appl Pharmacol. 1996;137:34\u201341.","journal-title":"Toxicol Appl Pharmacol"},{"key":"491_CR23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0753-3322(99)80077-8","volume":"53","author":"DG Couteur Le","year":"1999","unstructured":"Le Couteur DG, Mc Lean AJ, Taylor MC, Woodham BL, Board PG. Pesticides and Parkinson\u2019s disease. Biomed Pharmacother. 1999;53:122\u201330.","journal-title":"Biomed Pharmacother"},{"key":"491_CR24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwk024","volume":"165","author":"F Kamel","year":"2006","unstructured":"Kamel F, Tanner C, Umbach D, Hoppin JA, Alavanja MCR, Blair A, et al. Pesticide exposure and self-reported Parkinson\u2019s disease in the agricultural health study. Am J Epidemiol. 2006;165:364\u201374.","journal-title":"Am J Epidemiol"},{"key":"491_CR25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/oem.2006.027003","volume":"64","author":"FD Dick","year":"2007","unstructured":"Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, et al. Environmental risk factors for Parkinson\u2019s disease and parkinsonism: the Geoparkinson study. Occup Environ Med. 2007;64:666\u201372.","journal-title":"Occup Environ Med"},{"key":"491_CR26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/cdd.2009.217","volume":"17","author":"C Berry","year":"2010","unstructured":"Berry C, La Vecchia C, Nicotera P. Paraquat and Parkinson\u2019s disease. Cell Death Differ. 2010;17:1115\u201325.","journal-title":"Cell Death Differ"},{"key":"491_CR27","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295\u2013300.","journal-title":"Proc R Soc Med"},{"key":"491_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/toxsci\/kfr113","volume":"122","author":"HO Adami","year":"2011","unstructured":"Adami HO, Berry SCL, Breckenridge CB, Smith LL, Swenberg JA, Trichopoulos D, et al. Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol Sci. 2011;122:223\u201334.","journal-title":"Toxicol Sci"},{"key":"491_CR29","first-page":"435","volume":"21","author":"A Priyadarshi","year":"2000","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson\u2019s disease and exposure to pesticides. Neurotoxicology. 2000;21:435\u201340.","journal-title":"Neurotoxicology"},{"key":"491_CR30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/enrs.2001.4264","volume":"86","author":"A Priyadarshi","year":"2001","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Priyardarshi SS. Environmental risk factors and Parkinson\u2019s disease: a metaanalysis. Environ Res. 2001;86:122\u20137.","journal-title":"Environ Res"},{"key":"491_CR31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1289\/ehp.1103881","volume":"120","author":"M Mark Van der","year":"2011","unstructured":"Van der Mark M, Brower M, Kromhout H, Nijssen P, Huss A, Vermeulen R. Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ Health Perspect. 2011;120:340\u20137.","journal-title":"Environ Health Perspect"},{"key":"491_CR32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","volume":"33","author":"C Freire","year":"2012","unstructured":"Freire C, Koifman S. Pesticide exposure and Parkinson\u2019s disease: epidemiological evidence of association. Neurotoxicology. 2012;33:947\u201371.","journal-title":"Neurotoxicology"},{"key":"491_CR33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/01.jom.0000174294.58575.3e","volume":"47","author":"AA Li","year":"2005","unstructured":"Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinson\u2019s disease. J Occup Environ Med. 2005;47:1059\u201387.","journal-title":"J Occup Environ Med"},{"key":"491_CR34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1289\/ehp.8095","volume":"114","author":"TP Brown","year":"2006","unstructured":"Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson\u2019s disease\u2014Is there a link? Environ Health Perspect. 2006;114:156\u201364.","journal-title":"Environ Health Perspect"},{"key":"491_CR35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.envint.2012.05.004","volume":"46","author":"G Maele-Fabry Van","year":"2012","unstructured":"Van Maele-Fabry G, Hoet P, Vilain F, Lison D. Occupational exposure to pesticides and Parkinson\u2019s disease: a systematic review and meta-analysis of cohort studies. Environ Int. 2012;46:30\u201343.","journal-title":"Environ Int"},{"key":"491_CR36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/10408444.2013.798719","volume":"43","author":"MT Allen","year":"2013","unstructured":"Allen MT, Levy LS. Parkinson\u2019s disease and pesticide exposure\u2014a new assessment. Crit Rev Toxicol. 2013;43:515\u201334.","journal-title":"Crit Rev Toxicol"},{"key":"491_CR37","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","volume":"80","author":"G Pezzoli","year":"2013","unstructured":"Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013;80:2035\u201341.","journal-title":"Neurology"},{"key":"491_CR38","doi-asserted-by":"crossref","unstructured":"Ntzani EE, Chondrogiorgi M, Nitritsos G, Tzoulaki I. Literature review on epidemiological studies linking exposure to pesticides and health effects. EFSA supporting publication:EN-497, 2013. http:\/\/onlinelibrary.wiley.com\/doi\/10.2903\/sp.efsa.2013.EN-497\/abstract . Accessed 09 May 2017.","DOI":"10.2903\/sp.efsa.2013.EN-497"},{"key":"491_CR39","doi-asserted-by":"crossref","first-page":"e0151841","DOI":"10.1371\/journal.pone.0151841","volume":"11","author":"CB Breckenridge","year":"2016","unstructured":"Breckenridge CB, Berry C, Chang ET, Sielken RL, Mandel JS. Association between Parkinson\u2019s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis. PLoS ONE. 2016;11:e0151841.","journal-title":"PLoS ONE"},{"key":"491_CR40","unstructured":"Koustas E, Lam J, Sutton P, Johnson PI, Atchley D, Sen S, et al. Applying the navigation guide: case study #1. The Impact of Developmental Exposure to Perfluorooctanoic Acid (PFOA) On Fetal Growth. A Systematic Review of the Non-Human Evidence-Protocol, 2013. http:\/\/www.prhe.ucsf.edu\/prhe\/pdfs\/PFOA%20Human%20Protocol.pdf .\u00a0Accessed 09 May 2017."},{"key":"491_CR41","unstructured":"NTP (National Toxicology Program). Handbook for conducting a literature-based health assessment using OHAT approach for systematic review and evidence integration. Office of Health Assessment and Translation (OHAT), 2015. http:\/\/ntp.niehs.nih.gov\/ntp\/ohat\/pubs\/handbookjan2015_508.pdf .\u00a0Accessed 14 July 2016."},{"key":"491_CR42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1039\/C5TX00472A","volume":"5","author":"C Berry","year":"2016","unstructured":"Berry C. The dangers of hazards. Toxicol Res. 2016;5:373\u20136.","journal-title":"Toxicol Res"},{"key":"491_CR43","doi-asserted-by":"crossref","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A (deceased), Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMAP) 2015: elaboration and explanation. BMJ. 2015;2:g7647.","DOI":"10.1136\/bmj.g7647"},{"key":"491_CR44","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"491_CR45","volume-title":"OHAT risk of bias rating tool for human and animal studies","author":"OHAT (Office of Health Assessment and Translation)","year":"2015","unstructured":"OHAT (Office of Health Assessment and Translation). OHAT risk of bias rating tool for human and animal studies. 2015. http:\/\/ntp.niehs.nih.gov\/ntp\/ohat\/pubs\/riskofbiastool_508.pdf . Accessed 03 Nov 2016."},{"key":"491_CR46","unstructured":"Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. http:\/\/handbook.cochrane.org\/ . Accessed 11 Nov 2016."},{"key":"491_CR47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"491_CR48","volume-title":"Users\u2019 guides to the medical literature: a manual for evidence based clinical practice","author":"MH Murad","year":"2008","unstructured":"Murad MH, Montori V, Ioannidis J, Prasad K, Cook DJ, Guyatt G. Advanced topics in systematic reviews. Fixed-effects and random-effects models. In: Guyatt G, Rennie D, Meade M, Cook D, editors. Users\u2019 guides to the medical literature: a manual for evidence based clinical practice. Hamilton: McGraw-Hill; 2008. http:\/\/jamaevidence.mhmedical.com\/content.aspx?bookid=847&sectionid=69031503 . Accessed 30 Nov 2016."},{"key":"491_CR49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneumeth.2013.09.010","volume":"221","author":"HM Vesterinen","year":"2014","unstructured":"Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, et al. Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods. 2014;221:92\u2013102.","journal-title":"J Neurosci Methods"},{"key":"491_CR50","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046\u201355.","journal-title":"J Clin Epidemiol"},{"key":"491_CR51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"491_CR52","first-page":"CD006663","volume":"7","author":"R Dib El","year":"2016","unstructured":"El Dib R, Gomaa H, Carvalho RP, Camargo SE, Bazan R, Barretti P, et al. Enzyme replacement therapy for Anderson-Fabry disease. Cochrane Database Syst Rev. 2016;7:CD006663.","journal-title":"Cochrane Database Syst Rev"},{"key":"491_CR53","doi-asserted-by":"crossref","unstructured":"McGuinness MB, Karahalios A, Finger RP, Guymer RH, Simpson JA. Age-related macular degeneration and mortality: a systematic review and meta-analysis. Ophthalmic Epidemiol. 2017;24:141\u201352.","DOI":"10.1080\/09286586.2016.1259422"},{"key":"491_CR54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijsu.2016.12.007","volume":"37","author":"Z Wang","year":"2017","unstructured":"Wang Z, Xiao L, Guo H, Zhao G, Ma J. The efficiency and safety of fibrin sealant for reducing blood loss in primary total hip arthroplasty: a systematic review and meta-analysis. Int J Surg. 2017;37:50\u20137.","journal-title":"Int J Surg"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T13:22:10Z","timestamp":1569331330000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0491-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0491-x","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"article-number":"98"}}